Also, research still ongoing on the cannabinoid front, still researching how to leverage the endocannabinoid system’s power with CiaB encapsulation of THC and CBD prodrugs.
For example, some pediatric studies show that the cannabinoid receptor of the endocannabinoid system could be potentially causing shrinkage of certain brain tumors. There is the possibility of CiaB's targeted therapy, encapsulating prodrugs, can achieve this...but again, studies continue.
Very fluid here with PMCB having multiple projects occurring at the same time. However, their PC therapy is soooo close. So very close. :) :) :)
Go PharmaCyte!!!
Market Data 
Markets 
AI
